HDFC Pharma and Healthcare Fund(G)-Direct Plan

HDFC Pharma and Healthcare Fund(G)-Direct Plan is a part of HDFC Asset Management Company Limited, it was incepted on 04 Oct 2023. This fund is managed by Nikhil Mathur. It is a Equity type of fund.

The current NAV of HDFC Pharma and Healthcare Fund(G)-Direct Plan is ₹23.49 (as of 13 Nov 2026).

HDFC Pharma and Healthcare Fund(G)-Direct Plan has delivered 31.60% in 1 year, 31.25% in 3 years, and 0.00% in 5 years (annualised).

The minimum SIP amount for HDFC Pharma and Healthcare Fund(G)-Direct Plan is ₹100.

The expense ratio of HDFC Pharma and Healthcare Fund(G)-Direct Plan is 0.92%.

PRO Mutual Fund Advisory is Univest's personalised mutual fund advisory service. We analyse your portfolio, risk protile and goals to recommend the right mix of funds for you.

Anyone looking for personalised fund guidance—whether you're starting your MF journey or existing investors who want guidance on improving or restructuring their existing MF portfolio

Our recommendations are built on your profile, risk level, goals, existing portfolio, and Univest's proprietary fund ratings, not generic lists or trending funds.

A. Basic (PRO MF) - Get a personalised basket built for your goals and risk level, along with a complete portfolio health check, quarterly rebalancing guidance, and smart insights to optimise your returns.
B. Premium Advisory - Everything in Basic, plus dedicated 1:1 expert calls, deeper portfolio reviews, personalised reports, and priority support to help you make confident, well-guided investment decisions.

You can choose to execute them from any platform you already use. However, executing on Univest gives you a smoother experience with one-click investing and effortless rebalancing